Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S100B and CXCL9 as markers of activity in non-segmental vitiligo
PACTR201810545064445Recruiting
- Sponsor
- Cairo University
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dexamethasone in Vitiligo, sponsored by Cairo University. Primary endpoint: Relation between S100B, CXCL9 and vitiligo activity. Started Oct 2018; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on PACTR201810545064445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201810545064445.